Anorectal Cancer in Crohn’s Disease Has a Poor Prognosis Due to its Advanced Stage and Aggressive Histological Features: a Systematic Literature Review of Japanese Patients

Journal of Gastrointestinal Cancer

Volumn 51, Issue 1, 2020, Pages 1-9

  Ueda, Takeshi ^a,b   Inoue, Takashi ^b,c   Nakamoto, Takayuki ^b   Nishigori, Naoto ^b,d   Kuge, Hiroyuki ^b   Sasaki, Yoshiyuki ^b   Fujii, Hisao ^c,e   Koyama, Fumikazu ^b,c  

^a Minami Nara General Medical Center   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^d Nishigori Hospital   (Japan)

^e Gastrointestinal Endoscopy and IBD Center   (Japan)

Author keywords

Anorectal cancer; Crohn s disease; Surveillance colonoscopy

Indexed keywords

ADVANCED CANCER; ANORECTAL DISEASE; ANUS CANCER; ARTICLE; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; COLLOID CARCINOMA; COLONOSCOPY; CROHN DISEASE; DISEASE ASSOCIATION; EARLY CANCER; HISTOPATHOLOGY; HUMAN; JAPANESE (PEOPLE); LYMPH NODE METASTASIS; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; RECTUM CANCER; SIGNET RING CARCINOMA; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL MARGIN; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TUMOR INVASION; ADULT; AGED; ANUS TUMOR; COMPLICATION; FEMALE; JAPAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM TUMOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CROHN DISEASE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 85057482750     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-018-0180-6     Document Type: Article

References (35)

1. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.
2. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.
3. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–9.
4. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn’s disease and colorectal cancer. Gut. 1994;35:651–5.
5. Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.
6. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Nørgård B, et al. Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based Danish follow-up study. Am J Gastroenterol. 2007;102:163–7.
7. Stahl TJ, Schoetz DJ Jr, Roberts PL, Coller JA, Murray JJ, Silverman ML, et al. Crohn's disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992;35:850–6.
8. Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Fukuda Y, et al. Intestinal cancer in Crohn’s disease. Hepatogastroenterology. 2008;55:2121–4.
9. Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.
10. Higashi D, Futami K, Kawahara K, Kamitani T, Seki K, Naritomi K, et al. Study of colorectal cancer with Crohn’s disease. Anticancer Res. 2007;27:3771–4.
11. Higashi D, Katsuno H, Kimura H, Takahashi K, Ikeuchi H, Kono T, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.
12. Yano Y, Matsui T, Uno H, Hirai F, Futami K, Iwashita A. Risks and clinical features of colorectal cancer complicating Crohn’s disease in Japanese patients. J Gastroenterol Hepatol. 2008;23:1683–8.
13. Yano Y, Matsui T, Hirai F, Okado Y, Sato Y, Tsurumi K, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.
14. Hayashi T, Nakamura T, Kurachi K, Fukazawa A, Nakajima A, Nakamura K, et al. Crohn’s disease-associated colorectal cancer in Japan: report of four cases. Int J Color Dis. 2007;22:1537–42.
15. PRISMA PRISMA statement. Available from: URL: http://www.prisma-statement.org/. Accessed on Sep 10, 2013
16. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Japanese Society for Cancer of the Colon and Rectum: ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802–8.
17. Ueno H, Mochizuki H, Shirouzu K, Kusumi T, Yamada K, Ikegami M, et al. Study group for tumor deposits without lymph node structure in colorectal cancer projected by the Japanese Society for Cancer of the Colon and Rectum: multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Ann Surg. 2012;255:739–46.
18. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn’s colitis. Gastroenterology. 2001;120:820–6.
19. Lad SV, Haider MA, Brown CJ, Mcleod RS. MRI appearance of perianal carcinoma in Crohn’s disease. J Magn Reson Imaging. 2007;26:1659–62.
20. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum. 1998;41:992–6.
21. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohns disease. Gut. 1994;35:347–52.
22. Shwaartz C, Munger JA, Deliz JR, Bornstein JE, Gorfine SR, Chessin DB, et al. Fistula-associated anorectal cancer in the setting of Crohn’s disease. Dis Colon Rectum. 2016;59:1168–73.
23. Lightner AL, Moncrief SB, Smyrk TC, Pemberton JH, Haddock MG, Larson DW, et al. Long-standing Crohn’s disease and its implication on anal squamous cell cancer management. Int J Color Dis. 2017;32:661–6.
24. Thomas M, Bienkowski R, Vandermeer TJ, Trostle D, Cagir B. Malignant transformation in perianal fistulas of Crohn’s disease: a systematic review of literature. J Gastrointest Surg. 2010;14:66–73.
25. Matsuno H, Mizushima T, Nezu R, Nakajima K, Takahashi H, Haraguchi N, et al. Detection of anorectal cancer among patients with Crohn’s disease undergoing surveillance with various biopsy methods. Digestion. 2016;94:24–9.
26. Baars JE, Kuipers EJ, van Haastert M, Nicolaï JJ, Poen AC, van der Woude CJ. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol. 2012;47:1308–22.
27. Lutgens MW, Oldenburg B, Siersema PD, van Bodegraven AA, Dijkstra G, Hommes DW, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671–5.
28. Rutter MD. Surveillance programmes for neoplasia in colitis. J Gastroenterol. 2011;46(Suppl 1):1–5.
29. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.
30. Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn’s colitis: a case-control study. Inflamm Bowel Dis. 2006;12:491–6.
31. Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63:558–65.
32. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74.
33. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–65.
34. Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T, et al. Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.
35. Ogawa H, Haneda S, Shibata C, Miura K, Nagao M, Ohnuma S, et al. Adenocarcinoma associated with perianal fistulas in Crohn's disease. Anticancer Res. 2013;33:685–9.